+1-888-308-5802     
News Contact Us

J&J and DePuy to settle hip-implant claims with USD 120 million

Author : Ojaswita Kutepatil | Published Date : 2019-01-24 

The American medical devices and pharmaceutical giant Johnson & Johnson and its orthopedic and neurosurgery unit DePuy Orthopaedics have reportedly agreed to settle $120 million to resolve false marketing claims on its hip-implant devices by several state prosecutors.

According to sources familiar with the matter, 46 U.S. state attorney generals, including New York Attorney General Letitia James, alleged that J&J’s subsidiary DePuy used “unfair & deceptive” promotional practices for its Pinnacle Ultamet and ASR XL hip-implant devices and made misleading claims on the longevity of the implants.  

Doctors and their patients need to have exact information about medical devices and implants to ensure that patients are receiving proper healthcare, Letitia James revealed in a statement. She further claimed that companies should never be permitted to mislead the consumers, particularly when there are serious health concerns involved.

It has been reported that patients needed to frequently undergo a revision surgery even before DePuy’s advertised span for over five years.

DePuy said that the settlement does not involves any misconduct or admission of liability on the part of companies and it will remain committed in meeting the present and upcoming needs of patients and surgeons.

If reliable reports are to be believed, according to Letitia James, the New York Attorney General, DePuy is said to maintain a post-market surveillance program and is required to update procedures to track complaints pertaining to the hip implants, as a part of the settlement.

Sources cite that patients with failures in hip implant device also reported allergic reactions, groin pain, tissue necrosis, and build-up of metal ions in their blood.

As reported by Reuters, in 2010, DePuy announced a voluntary recall of nearly 93,000 ASR XL, saying that about 12% of them failed within 5 years. The company has since then settled thousands of lawsuits from hip-implant patients who had to have the ASR XL removed.

Similar lawsuits have also been filled against J&J and DePuy outside U.S., including Ireland, Australia, Italy, United Kingdom, Canada, and Italy.

About Author

Ojaswita Kutepatil

Ojaswita Kutepatil

Equipped with an ardent interest in writing, Ojaswita Kutepatil, a content developer by profession, presently writes articles for fractovia.org and a couple of other portals. When she isn’t harnessing the power of the pen, she loves to pursue her hobbies of cooking, reading, and crafting, to name a few. She can be contacted at- [email protected] | https://twitter.com/ojaswita_k

Related News

Adaptive3D secures financing from latest Series A investment round

Published Date: 2019-02-06         Author: Ojaswita Kutepatil

Applied Ventures LLC and DSM Venturing led the Series A investment round.   The investment round also saw participation from Chemence & current investors that were led by late Margaret McDermott & Mary McDermott Cook. Adaptive3D Technologies (Adaptive3D), an American additiv... Read More

Uber Eats to pilot Coles’ ready-to-eat meals in a new partnership deal

Published Date: 2019-01-29         Author: Ojaswita Kutepatil

The supermarket giant Coles has teamed up with Uber Eats to test-launch meal delivery services across Australia Uber Eats, an American online food delivery platform, and Australian supermarket chain Coles, have reportedly signed a partnership agreement for meal delivery to customers. Under the pa... Read More

Nestle Skin Health officially opens new branch in Kuala Lumpur

Published Date: 2019-01-22         Author: Ojaswita Kutepatil

Nestle Skin Health, a part of Nestle’s global business portfolio, has recently announced the opening of a new affiliate in Kuala Lumpur, Malaysia, in a major effort to consolidate footprints in the Asia-Pacific region. Reportedly, the global leader in skin health is endeavoring to tap into the... Read More

© 2019 Fractovia. All Rights Reserved